WO2001055320A8 - Nucleic acids, proteins, and antibodies - Google Patents
Nucleic acids, proteins, and antibodiesInfo
- Publication number
- WO2001055320A8 WO2001055320A8 PCT/US2001/001339 US0101339W WO0155320A8 WO 2001055320 A8 WO2001055320 A8 WO 2001055320A8 US 0101339 W US0101339 W US 0101339W WO 0155320 A8 WO0155320 A8 WO 0155320A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- reproductive system
- polypeptides
- polynucleotides
- methods
- further relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001243134A AU2001243134A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
US09/908,711 US20020045230A1 (en) | 2000-08-14 | 2001-07-20 | Nucleic acids, proteins, and antibodies |
Applications Claiming Priority (235)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17906500P | 2000-01-31 | 2000-01-31 | |
US60/179,065 | 2000-01-31 | ||
US18062800P | 2000-02-04 | 2000-02-04 | |
US60/180,628 | 2000-02-04 | ||
US18466400P | 2000-02-24 | 2000-02-24 | |
US60/184,664 | 2000-02-24 | ||
US18635000P | 2000-03-02 | 2000-03-02 | |
US60/186,350 | 2000-03-02 | ||
US18987400P | 2000-03-16 | 2000-03-16 | |
US60/189,874 | 2000-03-16 | ||
US19007600P | 2000-03-17 | 2000-03-17 | |
US60/190,076 | 2000-03-17 | ||
US19812300P | 2000-04-18 | 2000-04-18 | |
US60/198,123 | 2000-04-18 | ||
US20551500P | 2000-05-19 | 2000-05-19 | |
US60/205,515 | 2000-05-19 | ||
US20946700P | 2000-06-07 | 2000-06-07 | |
US60/209,467 | 2000-06-07 | ||
US21488600P | 2000-06-28 | 2000-06-28 | |
US60/214,886 | 2000-06-28 | ||
US21513500P | 2000-06-30 | 2000-06-30 | |
US60/215,135 | 2000-06-30 | ||
US21664700P | 2000-07-07 | 2000-07-07 | |
US21688000P | 2000-07-07 | 2000-07-07 | |
US60/216,880 | 2000-07-07 | ||
US60/216,647 | 2000-07-07 | ||
US21749600P | 2000-07-11 | 2000-07-11 | |
US21748700P | 2000-07-11 | 2000-07-11 | |
US60/217,496 | 2000-07-11 | ||
US60/217,487 | 2000-07-11 | ||
US21829000P | 2000-07-14 | 2000-07-14 | |
US60/218,290 | 2000-07-14 | ||
US22096300P | 2000-07-26 | 2000-07-26 | |
US22096400P | 2000-07-26 | 2000-07-26 | |
US60/220,964 | 2000-07-26 | ||
US60/220,963 | 2000-07-26 | ||
US22575900P | 2000-08-14 | 2000-08-14 | |
US22575800P | 2000-08-14 | 2000-08-14 | |
US22544700P | 2000-08-14 | 2000-08-14 | |
US22526600P | 2000-08-14 | 2000-08-14 | |
US22451800P | 2000-08-14 | 2000-08-14 | |
US22527000P | 2000-08-14 | 2000-08-14 | |
US22526700P | 2000-08-14 | 2000-08-14 | |
US22575700P | 2000-08-14 | 2000-08-14 | |
US22451900P | 2000-08-14 | 2000-08-14 | |
US22521300P | 2000-08-14 | 2000-08-14 | |
US22526800P | 2000-08-14 | 2000-08-14 | |
US22521400P | 2000-08-14 | 2000-08-14 | |
US60/225,267 | 2000-08-14 | ||
US60/225,758 | 2000-08-14 | ||
US60/225,759 | 2000-08-14 | ||
US60/224,518 | 2000-08-14 | ||
US60/225,447 | 2000-08-14 | ||
US60/225,268 | 2000-08-14 | ||
US60/225,214 | 2000-08-14 | ||
US60/225,266 | 2000-08-14 | ||
US60/224,519 | 2000-08-14 | ||
US60/225,213 | 2000-08-14 | ||
US60/225,270 | 2000-08-14 | ||
US60/225,757 | 2000-08-14 | ||
US22627900P | 2000-08-18 | 2000-08-18 | |
US60/226,279 | 2000-08-18 | ||
US22718200P | 2000-08-22 | 2000-08-22 | |
US22686800P | 2000-08-22 | 2000-08-22 | |
US22668100P | 2000-08-22 | 2000-08-22 | |
US60/226,868 | 2000-08-22 | ||
US60/227,182 | 2000-08-22 | ||
US60/226,681 | 2000-08-22 | ||
US22700900P | 2000-08-23 | 2000-08-23 | |
US60/227,009 | 2000-08-23 | ||
US22892400P | 2000-08-30 | 2000-08-30 | |
US60/228,924 | 2000-08-30 | ||
US22934400P | 2000-09-01 | 2000-09-01 | |
US22934500P | 2000-09-01 | 2000-09-01 | |
US22934300P | 2000-09-01 | 2000-09-01 | |
US22928700P | 2000-09-01 | 2000-09-01 | |
US60/229,343 | 2000-09-01 | ||
US60/229,344 | 2000-09-01 | ||
US60/229,345 | 2000-09-01 | ||
US60/229,287 | 2000-09-01 | ||
US22951300P | 2000-09-05 | 2000-09-05 | |
US22950900P | 2000-09-05 | 2000-09-05 | |
US60/229,513 | 2000-09-05 | ||
US60/229,509 | 2000-09-05 | ||
US23043800P | 2000-09-06 | 2000-09-06 | |
US23043700P | 2000-09-06 | 2000-09-06 | |
US60/230,438 | 2000-09-06 | ||
US60/230,437 | 2000-09-06 | ||
US23141400P | 2000-09-08 | 2000-09-08 | |
US23124300P | 2000-09-08 | 2000-09-08 | |
US23141300P | 2000-09-08 | 2000-09-08 | |
US23124200P | 2000-09-08 | 2000-09-08 | |
US23208100P | 2000-09-08 | 2000-09-08 | |
US23208000P | 2000-09-08 | 2000-09-08 | |
US23124400P | 2000-09-08 | 2000-09-08 | |
US60/232,081 | 2000-09-08 | ||
US60/231,414 | 2000-09-08 | ||
US60/231,243 | 2000-09-08 | ||
US60/231,242 | 2000-09-08 | ||
US60/231,244 | 2000-09-08 | ||
US60/231,413 | 2000-09-08 | ||
US60/232,080 | 2000-09-08 | ||
US23196800P | 2000-09-12 | 2000-09-12 | |
US60/231,968 | 2000-09-12 | ||
US23306400P | 2000-09-14 | 2000-09-14 | |
US23240000P | 2000-09-14 | 2000-09-14 | |
US23306300P | 2000-09-14 | 2000-09-14 | |
US23239700P | 2000-09-14 | 2000-09-14 | |
US23239800P | 2000-09-14 | 2000-09-14 | |
US23240100P | 2000-09-14 | 2000-09-14 | |
US23306500P | 2000-09-14 | 2000-09-14 | |
US23239900P | 2000-09-14 | 2000-09-14 | |
US60/232,401 | 2000-09-14 | ||
US60/232,398 | 2000-09-14 | ||
US60/233,064 | 2000-09-14 | ||
US60/233,065 | 2000-09-14 | ||
US60/232,400 | 2000-09-14 | ||
US60/233,063 | 2000-09-14 | ||
US60/232,399 | 2000-09-14 | ||
US60/232,397 | 2000-09-14 | ||
US23422300P | 2000-09-21 | 2000-09-21 | |
US23427400P | 2000-09-21 | 2000-09-21 | |
US60/234,274 | 2000-09-21 | ||
US60/234,223 | 2000-09-21 | ||
US23499800P | 2000-09-25 | 2000-09-25 | |
US23499700P | 2000-09-25 | 2000-09-25 | |
US60/234,998 | 2000-09-25 | ||
US60/234,997 | 2000-09-25 | ||
US23548400P | 2000-09-26 | 2000-09-26 | |
US60/235,484 | 2000-09-26 | ||
US23583400P | 2000-09-27 | 2000-09-27 | |
US23583600P | 2000-09-27 | 2000-09-27 | |
US60/235,834 | 2000-09-27 | ||
US60/235,836 | 2000-09-27 | ||
US23636700P | 2000-09-29 | 2000-09-29 | |
US23632700P | 2000-09-29 | 2000-09-29 | |
US23636900P | 2000-09-29 | 2000-09-29 | |
US23637000P | 2000-09-29 | 2000-09-29 | |
US23636800P | 2000-09-29 | 2000-09-29 | |
US60/236,370 | 2000-09-29 | ||
US60/236,367 | 2000-09-29 | ||
US60/236,327 | 2000-09-29 | ||
US60/236,368 | 2000-09-29 | ||
US60/236,369 | 2000-09-29 | ||
US23703700P | 2000-10-02 | 2000-10-02 | |
US23703900P | 2000-10-02 | 2000-10-02 | |
US23704000P | 2000-10-02 | 2000-10-02 | |
US23703800P | 2000-10-02 | 2000-10-02 | |
US23680200P | 2000-10-02 | 2000-10-02 | |
US60/237,039 | 2000-10-02 | ||
US60/236,802 | 2000-10-02 | ||
US60/237,040 | 2000-10-02 | ||
US60/237,037 | 2000-10-02 | ||
US60/237,038 | 2000-10-02 | ||
US23993500P | 2000-10-13 | 2000-10-13 | |
US23993700P | 2000-10-13 | 2000-10-13 | |
US60/239,935 | 2000-10-13 | ||
US60/239,937 | 2000-10-13 | ||
US24182600P | 2000-10-20 | 2000-10-20 | |
US24096000P | 2000-10-20 | 2000-10-20 | |
US24122100P | 2000-10-20 | 2000-10-20 | |
US24180900P | 2000-10-20 | 2000-10-20 | |
US24178500P | 2000-10-20 | 2000-10-20 | |
US24178700P | 2000-10-20 | 2000-10-20 | |
US24180800P | 2000-10-20 | 2000-10-20 | |
US24178600P | 2000-10-20 | 2000-10-20 | |
US60/240,960 | 2000-10-20 | ||
US60/241,809 | 2000-10-20 | ||
US60/241,786 | 2000-10-20 | ||
US60/241,826 | 2000-10-20 | ||
US60/241,221 | 2000-10-20 | ||
US60/241,787 | 2000-10-20 | ||
US60/241,785 | 2000-10-20 | ||
US60/241,808 | 2000-10-20 | ||
US24461700P | 2000-11-01 | 2000-11-01 | |
US60/244,617 | 2000-11-01 | ||
US24653200P | 2000-11-08 | 2000-11-08 | |
US24647700P | 2000-11-08 | 2000-11-08 | |
US24652500P | 2000-11-08 | 2000-11-08 | |
US24652800P | 2000-11-08 | 2000-11-08 | |
US24661000P | 2000-11-08 | 2000-11-08 | |
US24652700P | 2000-11-08 | 2000-11-08 | |
US24661100P | 2000-11-08 | 2000-11-08 | |
US24652600P | 2000-11-08 | 2000-11-08 | |
US24647500P | 2000-11-08 | 2000-11-08 | |
US24647400P | 2000-11-08 | 2000-11-08 | |
US24647600P | 2000-11-08 | 2000-11-08 | |
US60/246,611 | 2000-11-08 | ||
US60/246,532 | 2000-11-08 | ||
US60/246,523 | 2000-11-08 | ||
US60/246,477 | 2000-11-08 | ||
US60/246,527 | 2000-11-08 | ||
US60/246,475 | 2000-11-08 | ||
US60/246,610 | 2000-11-08 | ||
US60/246,476 | 2000-11-08 | ||
US60/246,525 | 2000-11-08 | ||
US60/246,613 | 2000-11-08 | ||
US60/246,609 | 2000-11-08 | ||
US60/246,474 | 2000-11-08 | ||
US60/246,528 | 2000-11-08 | ||
US60/246,526 | 2000-11-08 | ||
US60/246,478 | 2000-11-08 | ||
US60/246,524 | 2000-11-08 | ||
US60/249,244 | 2000-11-17 | ||
US60/249,297 | 2000-11-17 | ||
US60/249,216 | 2000-11-17 | ||
US60/249,217 | 2000-11-17 | ||
US60/249,211 | 2000-11-17 | ||
US60/249,209 | 2000-11-17 | ||
US60/249,300 | 2000-11-17 | ||
US60/249,265 | 2000-11-17 | ||
US60/249,210 | 2000-11-17 | ||
US60/249,214 | 2000-11-17 | ||
US60/249,208 | 2000-11-17 | ||
US60/249,207 | 2000-11-17 | ||
US60/249,212 | 2000-11-17 | ||
US60/249,264 | 2000-11-17 | ||
US60/249,213 | 2000-11-17 | ||
US60/249,245 | 2000-11-17 | ||
US60/249,299 | 2000-11-17 | ||
US60/249,218 | 2000-11-17 | ||
US60/249,215 | 2000-11-17 | ||
US60/250,391 | 2000-12-01 | ||
US60/250,160 | 2000-12-01 | ||
US60/256,719 | 2000-12-05 | ||
US60/251,988 | 2000-12-05 | ||
US60/251,030 | 2000-12-05 | ||
US60/251,479 | 2000-12-06 | ||
US60/251,989 | 2000-12-08 | ||
US60/251,869 | 2000-12-08 | ||
US60/251,856 | 2000-12-08 | ||
US60/251,990 | 2000-12-08 | ||
US60/251,868 | 2000-12-08 | ||
US60/254,097 | 2000-12-11 | ||
US60/259,678 | 2001-01-05 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/908,711 Continuation-In-Part US20020045230A1 (en) | 2000-08-14 | 2001-07-20 | Nucleic acids, proteins, and antibodies |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2001055320A2 WO2001055320A2 (en) | 2001-08-02 |
WO2001055320A8 true WO2001055320A8 (en) | 2001-09-07 |
WO2001055320A3 WO2001055320A3 (en) | 2002-04-11 |
Family
ID=27587117
Family Applications (48)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/001357 WO2001055208A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001353 WO2001055206A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001355 WO2001055207A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001327 WO2001055203A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001341 WO2001055322A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001335 WO2001055319A2 (en) | 2000-01-31 | 2001-01-17 | Endocrine related nucleic acids, proteins and antibodies |
PCT/US2001/001313 WO2001055200A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001330 WO2001055447A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001349 WO2001054474A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001239 WO2001055301A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001344 WO2001055324A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001348 WO2001055368A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001306 WO2001055307A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001310 WO2001055387A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001315 WO2001055311A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001338 WO2001055367A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001339 WO2001055320A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001314 WO2001055310A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001351 WO2001055355A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001342 WO2001059064A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001324 WO2001055314A2 (en) | 2000-01-31 | 2001-01-17 | Digestive system related nucleic acids, proteins and antibodies |
PCT/US2001/001345 WO2001055325A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001312 WO2001054733A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins and antibodies |
PCT/US2001/001322 WO2001055343A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001343 WO2001055323A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001321 WO2001055312A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001301 WO2001055303A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001332 WO2001055318A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001316 WO2001054473A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001325 WO2001055202A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001240 WO2001055302A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001308 WO2001055364A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001326 WO2001055315A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001333 WO2001055448A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001358 WO2001055163A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001337 WO2001055205A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001356 WO2001055173A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001309 WO2001055308A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001354 WO2001057182A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001311 WO2001055309A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001302 WO2001055304A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001340 WO2001055321A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001328 WO2001055316A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001350 WO2001055350A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001336 WO2001055204A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001359 WO2001055328A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001352 WO2001055327A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001317 WO2001055201A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
Family Applications Before (16)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/001357 WO2001055208A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001353 WO2001055206A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001355 WO2001055207A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001327 WO2001055203A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001341 WO2001055322A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001335 WO2001055319A2 (en) | 2000-01-31 | 2001-01-17 | Endocrine related nucleic acids, proteins and antibodies |
PCT/US2001/001313 WO2001055200A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001330 WO2001055447A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001349 WO2001054474A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001239 WO2001055301A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001344 WO2001055324A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001348 WO2001055368A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001306 WO2001055307A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001310 WO2001055387A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001315 WO2001055311A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001338 WO2001055367A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
Family Applications After (31)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/001314 WO2001055310A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001351 WO2001055355A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001342 WO2001059064A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001324 WO2001055314A2 (en) | 2000-01-31 | 2001-01-17 | Digestive system related nucleic acids, proteins and antibodies |
PCT/US2001/001345 WO2001055325A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001312 WO2001054733A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins and antibodies |
PCT/US2001/001322 WO2001055343A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001343 WO2001055323A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001321 WO2001055312A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001301 WO2001055303A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001332 WO2001055318A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001316 WO2001054473A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001325 WO2001055202A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001240 WO2001055302A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001308 WO2001055364A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001326 WO2001055315A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001333 WO2001055448A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001358 WO2001055163A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001337 WO2001055205A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001356 WO2001055173A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001309 WO2001055308A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001354 WO2001057182A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001311 WO2001055309A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001302 WO2001055304A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001340 WO2001055321A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001328 WO2001055316A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001350 WO2001055350A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001336 WO2001055204A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001359 WO2001055328A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001352 WO2001055327A2 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
PCT/US2001/001317 WO2001055201A1 (en) | 2000-01-31 | 2001-01-17 | Nucleic acids, proteins, and antibodies |
Country Status (3)
Country | Link |
---|---|
AU (16) | AU2001241410A1 (en) |
CA (37) | CA2392438A1 (en) |
WO (48) | WO2001055208A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8932821B2 (en) | 2003-03-19 | 2015-01-13 | Biogen Idec Ma Inc. | NOGO receptor binding protein |
Families Citing this family (269)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020137890A1 (en) | 1997-03-31 | 2002-09-26 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US7579160B2 (en) | 1998-03-18 | 2009-08-25 | Corixa Corporation | Methods for the detection of cervical cancer |
US6960570B2 (en) | 1998-03-18 | 2005-11-01 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US6706262B1 (en) | 1998-03-18 | 2004-03-16 | Corixa Corporation | Compounds and methods for therapy and diagnosis of lung cancer |
US7258860B2 (en) | 1998-03-18 | 2007-08-21 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US7771719B1 (en) | 2000-01-11 | 2010-08-10 | Genentech, Inc. | Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E |
CA2328496C (en) | 1998-05-15 | 2016-01-05 | Genentech, Inc. | Il-17 homologous polypeptides and therapeutic uses thereof |
US6929938B2 (en) | 2001-08-15 | 2005-08-16 | Millennium Pharmaceuticals, Inc. | 25501, a human transferase family member and uses therefor |
US7141417B1 (en) | 1999-02-25 | 2006-11-28 | Thomas Jefferson University | Compositions, kits, and methods relating to the human FEZ1 gene, a novel tumor suppressor gene |
JP2003508011A (en) * | 1999-02-25 | 2003-03-04 | トマス・ジエフアーソン・ユニバーシテイ | Compositions, kits and methods relating to a novel tumor suppressor gene that is the human FEZ1 gene |
WO2000050458A1 (en) * | 1999-02-26 | 2000-08-31 | Smithkline Beecham Corporation | Cloning of a p2y-like 7tm receptor (axor17) |
AU3885400A (en) * | 1999-03-23 | 2000-10-09 | Human Genome Sciences, Inc. | 48 human secreted proteins |
EP1174509A4 (en) | 1999-03-29 | 2003-10-22 | Kansai Tech Licensing Org Co | Novel cytidine deaminase |
EP1623993A3 (en) * | 1999-09-01 | 2006-06-07 | Genetech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US7083944B1 (en) * | 1999-10-27 | 2006-08-01 | Millennium Pharmaceuticals, Inc. | Molecules of the card-related protein family and uses thereof |
US6893818B1 (en) | 1999-10-28 | 2005-05-17 | Agensys, Inc. | Gene upregulated in cancers of the prostate |
US7005499B1 (en) * | 1999-11-18 | 2006-02-28 | Genentech, Inc. | Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same |
EP1878795A3 (en) * | 1999-11-30 | 2008-01-23 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
CA2494705A1 (en) * | 1999-12-01 | 2001-06-07 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
CN1300781A (en) * | 1999-12-22 | 2001-06-27 | 上海博德基因开发有限公司 | Polypeptide-human SHC protein 43 and polynucleotide for coding this polypeptide |
US20040043397A1 (en) | 2000-01-11 | 2004-03-04 | Genentech, Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
ES2360155T3 (en) | 2000-01-26 | 2011-06-01 | Agensys, Inc. | 84P2A9: A SPECIFIC PROTEIN OF PROSTATE AND TESTICLES HIGHLY EXPRESSED IN PROSTATE CANCER. |
US6953682B2 (en) | 2000-02-10 | 2005-10-11 | Millennium Pharmaceuticals, Inc. | Nucleic acid sequences encoding adenylate kinase, phospholipid scramblase-like, DNA fragmentation factor-like, phosphatidylserine synthase-like, and atpase-like molecules and uses therefor |
US20020082212A1 (en) * | 2000-07-20 | 2002-06-27 | Millennium Pharmaceuticals, Inc. | 7716, a novel human ATPase and uses therefor |
US7078205B2 (en) | 2000-02-17 | 2006-07-18 | Millennium Pharmaceuticals, Inc. | Nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, atpase molecules, acyltransferase molecules, pyridoxal-phosphate dependent enzyme molecules and uses therefor |
US7718397B2 (en) | 2000-03-21 | 2010-05-18 | Genentech, Inc. | Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof |
AU2001250980A1 (en) * | 2000-03-23 | 2001-10-03 | Carmela Beger | Brca-1 regulators and methods of use |
EP1272640A2 (en) | 2000-03-24 | 2003-01-08 | Millennium Pharmaceuticals, Inc. | 3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor |
US20030198953A1 (en) * | 2000-03-30 | 2003-10-23 | Spytek Kimberly A. | Novel proteins and nucleic acids encoding same |
US7632929B2 (en) | 2000-04-20 | 2009-12-15 | The Board Of Trustees Of The University Of Arkansas | Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof |
AU2001257195B2 (en) * | 2000-04-25 | 2006-10-05 | Lexicon Pharmaceuticals, Inc. | Novel human kinase proteins and polynucleotides encoding the same |
EP1280917A2 (en) * | 2000-04-26 | 2003-02-05 | Millennium Pharmaceuticals, Inc. | 21657, a human short-chain dehydrogenase and uses thereof |
US6808876B1 (en) * | 2000-05-02 | 2004-10-26 | Immusol, Inc. | Cellular regulators of infectious agents and methods of use |
WO2001085921A2 (en) * | 2000-05-12 | 2001-11-15 | Merck Patent Gmbh | Human serine-threonine kinase-4 |
EP1307545A2 (en) * | 2000-05-26 | 2003-05-07 | Bayer Aktiengesellschaft | REGULATION OF HUMAN p78-LIKE SERINE/THREONINE KINASE |
EP1158001B1 (en) * | 2000-05-26 | 2007-11-14 | F. Hoffmann-La Roche Ag | A nucleic acid which is upregulated in human tumor cells, a protein encoded thereby and a process for tumor diagnosis |
DE10027170A1 (en) * | 2000-05-31 | 2001-12-13 | Schering Ag | Human PEM as a target for fertility control |
WO2001093805A2 (en) * | 2000-06-02 | 2001-12-13 | The Brigham & Women's Hospital, Inc. | FUSION OF jAZF1 AND jjAZ1 GENES IN ENDOMETIRIAL STROMAL TUMORS |
AU6531101A (en) * | 2000-06-02 | 2001-12-17 | Genentech Inc | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US20030096969A1 (en) | 2000-06-02 | 2003-05-22 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
EP1292677A2 (en) * | 2000-06-05 | 2003-03-19 | Bayer Aktiengesellschaft | Human hm74-like g protein coupled receptor |
US6323016B1 (en) | 2000-06-09 | 2001-11-27 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
CA2411278A1 (en) * | 2000-06-09 | 2001-12-20 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of colon cancer |
AU2001268435A1 (en) * | 2000-06-15 | 2001-12-24 | Millennium Pharmaceuticals, Inc. | 23680, a novel human aminotransferase and uses therefor |
AU2001269888A1 (en) * | 2000-06-16 | 2001-12-24 | Incyte Genomics, Inc. | Protein phosphatases |
EP2075253A1 (en) * | 2000-06-23 | 2009-07-01 | Genentech, Inc. | Compositions and methds for the diagnosis and treatment of disorders involving angiogensis |
EP1325114A2 (en) * | 2000-06-26 | 2003-07-09 | Millennium Pharmaceuticals, Inc. | A human beta-ketoacyl synthase (46619) and uses thereof |
JP2004501623A (en) * | 2000-06-27 | 2004-01-22 | キュラジェン コーポレイション | Polynucleotides and polypeptides encoded thereby |
US7094587B2 (en) | 2000-06-27 | 2006-08-22 | Millennium Pharmaceuticals, Inc. | 16002 Molecules and uses therefor |
AU2001271621A1 (en) | 2000-06-28 | 2002-01-08 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
AU2001273148A1 (en) | 2000-06-30 | 2002-01-14 | Millennium Pharmaceuticals, Inc. | 57658, a human uridine kinase and uses thereof |
WO2002004510A2 (en) * | 2000-07-07 | 2002-01-17 | Incyte Genomics, Inc. | Gtp-binding proteins |
JP2004513618A (en) * | 2000-07-07 | 2004-05-13 | インサイト・ゲノミックス・インコーポレイテッド | Transporters and ion channels |
EP1305428A2 (en) * | 2000-07-14 | 2003-05-02 | Millennium Pharmaceuticals, Inc. | 62088, a human nucleoside phosphatase family member and uses thereof |
AU2001281967A1 (en) * | 2000-07-18 | 2002-01-30 | Bayer Aktiengesellschaft | Regulation of human desc1-like serine protease |
US6740751B2 (en) | 2000-07-18 | 2004-05-25 | Board Of Regents, The University Of Texas System | Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells |
JP2004514420A (en) * | 2000-07-20 | 2004-05-20 | ジェネンテック・インコーポレーテッド | Secreted and transmembrane polypeptides and nucleic acids encoding them |
US20060252034A1 (en) * | 2000-07-25 | 2006-11-09 | Klaus Duecker | Novel protein containing ring finger domaine r1p4 |
AU2001277202A1 (en) * | 2000-07-26 | 2002-02-05 | Applied Genomics, Inc. | Bstp-ras/rerg protein and related reagents and methods of use thereof |
AU2001277200A1 (en) * | 2000-07-26 | 2002-02-05 | Applied Genomics, Inc. | Bstp-cad protein and related reagents and methods of use thereof |
US7335732B2 (en) | 2000-08-01 | 2008-02-26 | Genentech, Inc. | PRO9799 polypeptides |
EP1657254A3 (en) * | 2000-08-01 | 2006-06-07 | Genentech, Inc. | Polypeptide, nucleic acid encoding it, and their use for the diagnosis of cancer |
WO2002010217A2 (en) | 2000-08-02 | 2002-02-07 | The Johns Hopkins University | Endothelial cell expression patterns |
WO2003024276A1 (en) * | 2000-08-02 | 2003-03-27 | Millennium Pharmaceuticals,Inc. | A human gtp-releasing factor family member (15368) and uses therefor |
US6924364B2 (en) | 2000-08-04 | 2005-08-02 | Zymogenetics, Inc. | Human secreted protein, Zzp1 |
US6943245B2 (en) | 2000-08-10 | 2005-09-13 | Board Of Regents, The University Of Texas System | Tumor suppressor CAR-1 |
US7091022B2 (en) * | 2000-08-11 | 2006-08-15 | Merck Patent Gmbh | Mitogen activated kinase |
EP1326985A1 (en) * | 2000-08-18 | 2003-07-16 | MERCK PATENT GmbH | Identification of a human n-terminal acetyltransferase gene |
CA2417186A1 (en) * | 2000-08-21 | 2002-02-28 | Incyte Genomics, Inc. | Microtubule-associated proteins and tubulins |
US6706513B2 (en) | 2000-08-21 | 2004-03-16 | Bristol-Myers Squibb Company | Adenosine deaminase homolog |
WO2002016579A2 (en) * | 2000-08-24 | 2002-02-28 | Eli Lilly And Company | Nucleic acids, vectors, host cells, polypeptides and uses thereof |
WO2002018578A2 (en) * | 2000-08-28 | 2002-03-07 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer |
EP1334189A2 (en) * | 2000-08-28 | 2003-08-13 | AstraZeneca AB | Molecules involved in the regulation of insulin resistance syndrome (irs) |
CA2420902A1 (en) * | 2000-08-28 | 2002-03-07 | Craig A. Rosen | 18 human secreted proteins |
AU2001286714A1 (en) * | 2000-08-30 | 2002-03-13 | Millennium Pharmaceuticals, Inc. | 54370, a novel human sulfate transporter and uses therefor |
US20020146800A1 (en) * | 2000-08-30 | 2002-10-10 | Curtis Rory A.J. | 48921, a novel human GTP releasing factor and uses therefor |
WO2002018567A2 (en) * | 2000-08-30 | 2002-03-07 | Bayer Aktiengesellschaft | Regulation of human aminotransferase-like enzyme |
AU2001285908A1 (en) * | 2000-08-30 | 2002-03-13 | Bayer Aktiengesellschaft | Regulation of human aminotransferase-like enzyme |
WO2002018582A2 (en) * | 2000-08-31 | 2002-03-07 | Millennium Pharmaceuticals, Inc. | 62112, a novel human dehydrogenase and uses thereof |
CA2421588C (en) | 2000-09-05 | 2010-01-26 | Amgen Inc. | Tnf receptor-like molecules and uses thereof |
EP1364015A2 (en) * | 2000-09-05 | 2003-11-26 | Incyte Genomics, Inc. | Molecules for diagnostics and therapeutics |
US20020142464A1 (en) * | 2000-09-08 | 2002-10-03 | Millennium Pharmaceuticals, Inc. | 38646, a novel guanine nucleotide exchange factor and uses therefor |
US6372468B1 (en) | 2000-09-14 | 2002-04-16 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
US6391606B1 (en) * | 2000-09-14 | 2002-05-21 | Pe Corporation | Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
WO2002029058A2 (en) * | 2000-10-05 | 2002-04-11 | Curagen Corporation | Human proteins, polynucleotides encoding them and methods of using the same |
AU2002220613A1 (en) * | 2000-10-11 | 2002-04-22 | Bayer Aktiengesellschaft | Regulation of human cyclophilin-type peptidyl-prolyl cis-trans isomerase |
EP1402010A2 (en) * | 2000-10-11 | 2004-03-31 | Millennium Pharmaceuticals, Inc. | 8843, a human dual specificity phosphatase family member and uses therefor |
US20020064831A1 (en) * | 2000-10-12 | 2002-05-30 | The Texas A&M University System | Nucleic acid sequences encoding CMG proteins, CMG proteins, and methods for their use |
AU2002215345A1 (en) * | 2000-10-13 | 2002-04-22 | Eos Biotechnology, Inc. | Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer |
US6531297B2 (en) * | 2000-10-20 | 2003-03-11 | Applera Corporation | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
WO2002062945A2 (en) | 2000-10-25 | 2002-08-15 | Diadexus, Inc. | Compositions and methods relating to lung specific genes and proteins |
AU2002220668A1 (en) * | 2000-10-31 | 2002-05-15 | Bayer Aktiengesellschaft | Regulation of human glutathione-s-transferase |
WO2002038743A2 (en) * | 2000-11-09 | 2002-05-16 | Glaxo Group Limited | Deaminase catalyzing the removal of the cyclopropyl moiety from abacavir-mp |
EP1349934A2 (en) | 2000-11-20 | 2003-10-08 | Diadexus, Inc. | Compositions and methods relating to breast specific genes and proteins |
WO2002081667A2 (en) * | 2000-12-05 | 2002-10-17 | Incyte Genomics, Inc. | Ligases |
JP2004524825A (en) | 2000-12-07 | 2004-08-19 | ザイモジェネティクス,インコーポレイティド | Adipocyte complement-related protein ZACRP3X2 |
CA2430379A1 (en) | 2000-12-07 | 2002-06-13 | Chiron Corporation | Endogenous retroviruses up-regulated in prostate cancer |
CA2439800A1 (en) * | 2000-12-14 | 2002-06-20 | Pe Corporation (Ny) | Isolated human kinase proteins, their encoding nucleic acid molecules, and uses thereof |
US20020142376A1 (en) * | 2000-12-20 | 2002-10-03 | Gennady Merkulov | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
IL155687A0 (en) | 2000-12-22 | 2003-11-23 | Bristol Myers Squibb Co | Polynucleotides encoding hlrrsi1 polypeptides |
US7892730B2 (en) * | 2000-12-22 | 2011-02-22 | Sagres Discovery, Inc. | Compositions and methods for cancer |
US6423521B1 (en) * | 2000-12-28 | 2002-07-23 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
WO2002053591A1 (en) * | 2000-12-30 | 2002-07-11 | Lion Bioscience Ag | Mammalian nuclear receptor cofactor cf12 and methods of use |
WO2002053754A2 (en) * | 2001-01-08 | 2002-07-11 | Lexicon Genetics Incorporated | Human protease and polynucleotides encoding the same |
AU2002243750A1 (en) * | 2001-01-30 | 2002-08-12 | Regeneron Pharmaceuticals, Inc. | Novel nucleic acid and polypeptide molecules |
WO2002098917A2 (en) * | 2001-02-12 | 2002-12-12 | Curagen Corporation | Human proteins and nucleic acids encoding same |
EP1637601A3 (en) * | 2001-02-21 | 2006-03-29 | Curagen Corporation | Proteins, polynucleotides encoding them and methods of using the same |
US7271240B2 (en) | 2001-03-14 | 2007-09-18 | Agensys, Inc. | 125P5C8: a tissue specific protein highly expressed in various cancers |
AU2002250143A1 (en) * | 2001-03-16 | 2002-10-03 | Eli Lilly And Company | Lp mammalian proteins; related reagents |
US6913904B2 (en) * | 2001-03-27 | 2005-07-05 | Applera Corporation | Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof |
WO2002083921A2 (en) | 2001-04-10 | 2002-10-24 | Agensys, Inc. | Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers |
WO2002083860A2 (en) | 2001-04-10 | 2002-10-24 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer |
IL158293A0 (en) | 2001-04-10 | 2004-05-12 | Agensys Inc | Nucleic acid and corresponding protein entitled 158p3d2 and pharmaceutical compositions containing the same |
AU2002249453A1 (en) * | 2001-04-24 | 2002-11-05 | Isis Innovation Ltd | Enzyme and snp marker for disease |
EP1391462A4 (en) * | 2001-04-24 | 2004-09-15 | Otsuka Pharma Co Ltd | Crohn's disease antibody-binding peptide and method of examining crohn's disease |
KR100882762B1 (en) | 2001-05-07 | 2009-02-09 | 시오노기세이야쿠가부시키가이샤 | Polypeptide serving as angiogenic marker and dna thereof |
AU2002314048A1 (en) * | 2001-05-09 | 2002-11-18 | Bayer Aktiengesellschaft | Regulation of human phosphatidic acid phosphatase type 2c-like protein |
US6905827B2 (en) | 2001-06-08 | 2005-06-14 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases |
US7235358B2 (en) | 2001-06-08 | 2007-06-26 | Expression Diagnostics, Inc. | Methods and compositions for diagnosing and monitoring transplant rejection |
WO2003000901A2 (en) * | 2001-06-26 | 2003-01-03 | Decode Genetics Ehf. | Nucleic acids encoding protein kinases |
US20030120040A1 (en) | 2001-06-29 | 2003-06-26 | Genentech, Inc. | Secreted and Transmembrane polypeptides and nucleic acids encoding the same |
GB2399087A (en) * | 2001-08-02 | 2004-09-08 | Aeomica Inc | Human zinc finger containing gene MDZ7 |
JP2005504546A (en) * | 2001-08-17 | 2005-02-17 | インサイト・ゲノミックス・インコーポレイテッド | Intracellular signaling molecules |
US7270960B2 (en) * | 2001-08-29 | 2007-09-18 | Pacific Northwest Research Institute | Diagnosis of ovarian carcinomas |
WO2003023063A1 (en) * | 2001-09-07 | 2003-03-20 | Sankyo Company, Limited | Method of judging onset risk of diabetes |
WO2003040369A2 (en) * | 2001-09-17 | 2003-05-15 | Molecular Engines Laboratories | Sequences involved in tumoral suppression, tumoral reversion, apoptosis and/or viral resistance phenomena and their use as medicines |
WO2003025175A2 (en) * | 2001-09-17 | 2003-03-27 | Molecular Engines Laboratories | Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
WO2003029411A2 (en) | 2001-09-28 | 2003-04-10 | Brigham Young University | Novel cyclooxygenase variants and methods of use |
JPWO2003038087A1 (en) | 2001-10-04 | 2005-02-24 | 関西ティー・エル・オー株式会社 | Promoter of DR5 gene and promoter of Siah-1 gene |
US7084257B2 (en) | 2001-10-05 | 2006-08-01 | Amgen Inc. | Fully human antibody Fab fragments with human interferon-gamma neutralizing activity |
WO2003031607A1 (en) * | 2001-10-10 | 2003-04-17 | Bayer Healthcare Ag | Regulation of human short-chain dehydrogenase/reductase |
DE60220621T2 (en) | 2001-11-09 | 2008-03-06 | Proteologics, Inc. | Posh nucleic acid, polypeptides and related methods |
US7491690B2 (en) | 2001-11-14 | 2009-02-17 | Northwestern University | Self-assembly and mineralization of peptide-amphiphile nanofibers |
WO2003044197A1 (en) * | 2001-11-21 | 2003-05-30 | Japan Science And Technology Agency | Huntington’s disease gene transcriptional factors |
US7151162B2 (en) | 2001-12-06 | 2006-12-19 | The University Of Children's Hospital Of Both Cantons Of Basel | Nuclear protein |
AU2002339697A1 (en) * | 2001-12-19 | 2003-06-30 | Genset S.A. | Gmg-5 polynucleotides and polypeptides and uses thereof |
JP2003245084A (en) * | 2001-12-20 | 2003-09-02 | Morinaga Milk Ind Co Ltd | New gene useful for diagnosis and treatment of aplasia of corpus callosum and aspermatogenesis and use thereof |
DE10163467A1 (en) * | 2001-12-21 | 2003-11-27 | Axaron Bioscience Ag | New DNA sequence encoding protein 24B2, useful for treatment and diagnosis or cancer and degenerative diseases, also related polypeptides and modulators |
US6759222B2 (en) | 2002-01-02 | 2004-07-06 | Millennium Pharmaceuticals, Inc. | 14815, a human kinase family member and uses therefor |
WO2003057870A1 (en) * | 2002-01-07 | 2003-07-17 | Bayer Healthcare Ag | Human phosphatidic acid phosphatase type 2-like protein |
AU2003205611A1 (en) * | 2002-01-15 | 2003-07-30 | Medigene Ag | Dilated cardiomyopathy associated gene-2 (dcmag-2): a cytoplasmatic inducer of sarcomeric remodeling in cardiomyocytes |
AU2003235631A1 (en) * | 2002-01-15 | 2003-07-30 | Bayer Aktiengesellschaft | Human subtilisin/kexin-like convertase |
JPWO2003062429A1 (en) * | 2002-01-23 | 2005-05-26 | 山之内製薬株式会社 | New serine protease |
US7371719B2 (en) | 2002-02-15 | 2008-05-13 | Northwestern University | Self-assembly of peptide-amphiphile nanofibers under physiological conditions |
EP1338609A1 (en) * | 2002-02-21 | 2003-08-27 | MEMOREC Stoffel GmbH-Medizinisch-Molekulare Entwicklung, Köln | A further KDR receptor and the use thereof |
AU2003225666A1 (en) * | 2002-03-05 | 2003-09-22 | Applera Corporation | Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
WO2003074557A1 (en) * | 2002-03-06 | 2003-09-12 | Oxford Glycosciences (Uk) Ltd | Novel b-cell malignancy-associated protein |
EP2799555B1 (en) | 2002-03-13 | 2017-02-22 | Genomic Health, Inc. | Gene expression profiling in biopsied tumor tissues |
US7527935B2 (en) | 2002-03-19 | 2009-05-05 | Mitsubishi Tanabe Pharma Corporation | G-protein coupled receptor having eicosanoid as ligand and gene thereof |
JP3949111B2 (en) * | 2002-03-19 | 2007-07-25 | 田辺製薬株式会社 | Novel G protein-coupled receptor and gene thereof |
GB0206684D0 (en) * | 2002-03-21 | 2002-05-01 | Babraham Inst | Novel proteins |
US7193069B2 (en) | 2002-03-22 | 2007-03-20 | Research Association For Biotechnology | Full-length cDNA |
CA2413475C (en) | 2002-04-25 | 2010-07-27 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Zap-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (cll/sll) |
JP2004041003A (en) * | 2002-05-17 | 2004-02-12 | Takeda Chem Ind Ltd | New protein, its dna and use thereof |
AU2003238178A1 (en) | 2002-05-29 | 2003-12-12 | Develogen Aktiengesellschaft Fur Entwicklungsbiologische Forschung | Pancreas-specific proteins |
AU2003237367A1 (en) | 2002-06-03 | 2003-12-19 | Chiron Corporation | Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer |
EP2275544A3 (en) * | 2002-06-06 | 2011-03-30 | Oncotherapy Science, Inc. | Genes and polypeptides relating to human colon cancers |
CA2489292A1 (en) | 2002-06-13 | 2003-12-24 | Chiron Corporation | Vectors for expression of hml-2 polypeptides |
AU2003281626A1 (en) * | 2002-07-22 | 2004-02-09 | Masayoshi Harigai | Novel gene associated with rheumatoid arthritis |
CA2495177C (en) | 2002-08-14 | 2014-01-21 | National Institute Of Advanced Industrial Science And Technology | Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
US20040081653A1 (en) * | 2002-08-16 | 2004-04-29 | Raitano Arthur B. | Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer |
AU2003235316A1 (en) * | 2002-08-23 | 2004-03-11 | Japan Science And Technology Agency | Human solid cancer antigen peptides, polynucleotides encoding the same and utilization thereof |
US20060292564A1 (en) * | 2002-08-27 | 2006-12-28 | Epigenomics Ag | Method and nucleic acids for the analysis of breast cell proliferative disorders |
US7452969B2 (en) | 2002-08-30 | 2008-11-18 | Licentia Ltd | Neurotrophic factor protein and uses thereof |
JP4679149B2 (en) | 2002-09-30 | 2011-04-27 | オンコセラピー・サイエンス株式会社 | Genes and polypeptides related to human pancreatic cancer |
WO2004035823A2 (en) * | 2002-10-17 | 2004-04-29 | Evotec Neurosciences Gmbh | Diagnostic and therapeutic use of the nicotinamide mononucleotide adenylytransferase 2 (nmnat-2) gene and protein for neurodegenerative diseases |
AU2002952216A0 (en) * | 2002-10-23 | 2002-11-07 | The Walter And Eliza Hall Institute Of Medical Research | Novel therapeutic molecules |
US7554021B2 (en) | 2002-11-12 | 2009-06-30 | Northwestern University | Composition and method for self-assembly and mineralization of peptide amphiphiles |
US8008003B2 (en) | 2002-11-15 | 2011-08-30 | Genomic Health, Inc. | Gene expression profiling of EGFR positive cancer |
DE10254601A1 (en) | 2002-11-22 | 2004-06-03 | Ganymed Pharmaceuticals Ag | Gene products differentially expressed in tumors and their use |
AU2002953341A0 (en) * | 2002-12-13 | 2003-01-09 | The Walter And Eliza Hall Institute Of Medical Research | A novel phosphoprotein |
AU2003287764B2 (en) * | 2002-12-13 | 2010-01-21 | The Walter And Eliza Hall Institute Of Medical Research | A novel phosphoprotein |
US20040231909A1 (en) | 2003-01-15 | 2004-11-25 | Tai-Yang Luh | Motorized vehicle having forward and backward differential structure |
WO2004070025A2 (en) * | 2003-02-05 | 2004-08-19 | Juan Saus | Novel goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders |
EP1445614A1 (en) * | 2003-02-06 | 2004-08-11 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | A method for the in vitro assessment of the progression status of an HIV virus in an invidual |
US7074891B2 (en) | 2003-02-07 | 2006-07-11 | Posco | Leukocyte stimulating peptides |
DK1597391T3 (en) | 2003-02-20 | 2009-01-12 | Genomic Health Inc | Use of intron RNA to measure gene expression |
JPWO2004078784A1 (en) * | 2003-03-04 | 2006-06-08 | アステラス製薬株式会社 | Novel genes related to fibrotic conditions |
ITRM20030149A1 (en) | 2003-04-02 | 2004-10-03 | Giuliani Spa | ANTISENSE OLIGONUCLEOTIDES (ODN) FOR SMAD7 AND THEIR USE IN THE MEDICAL FIELD |
ES2488845T5 (en) | 2003-06-24 | 2017-07-11 | Genomic Health, Inc. | Prediction of the probability of cancer recurrence |
EP1644858B1 (en) | 2003-07-10 | 2017-12-06 | Genomic Health, Inc. | Expression profile algorithm and test for cancer prognosis |
ATE528397T1 (en) | 2003-08-08 | 2011-10-15 | Perseus Proteomics Inc | GENE OVEREXPRESSED IN CANCER |
WO2005018554A2 (en) * | 2003-08-12 | 2005-03-03 | Washington University In St. Louis | Isolated heat-inducible cell surface protein and hyperthermia-based tumor immunotargeting therapy |
US20070178458A1 (en) * | 2003-09-05 | 2007-08-02 | O'brien Philippa | Methods of diagnosis and prognosis of ovarian cancer II |
WO2005026314A2 (en) * | 2003-09-10 | 2005-03-24 | Japan Science And Technology Agency | Group of genes differentially expressed in peripheral blood cells and diagnostic method and assay method using the same |
DE602004028262D1 (en) * | 2003-10-02 | 2010-09-02 | Glaxosmithkline Biolog Sa | B. PERTUSSIS ANTIGENE AND ITS USE IN VACCINATION |
WO2005033144A2 (en) | 2003-10-03 | 2005-04-14 | Brigham And Women's Hospital | Tim-3 polypeptides |
WO2005040791A2 (en) * | 2003-10-21 | 2005-05-06 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with somatostatin- and angiogenin-like peptide receptor (salpr) |
WO2005051994A2 (en) * | 2003-11-21 | 2005-06-09 | Zymogenetics, Inc. | Ztnf11, a tumor necrosis factor |
KR20070004560A (en) | 2003-12-05 | 2007-01-09 | 노오쓰웨스턴 유니버시티 | Self-assembling peptide amphiphiles and related methods for growth factor delivery |
US20050196782A1 (en) | 2003-12-23 | 2005-09-08 | Kiefer Michael C. | Universal amplification of fragmented RNA |
US20050186577A1 (en) | 2004-02-20 | 2005-08-25 | Yixin Wang | Breast cancer prognostics |
LT3296407T (en) * | 2004-03-02 | 2019-09-10 | The Johns Hopkins University | Mutations of the pik3ca gene in human cancers |
TW200539890A (en) | 2004-03-12 | 2005-12-16 | Brigham & Womens Hospital | Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
WO2005090569A1 (en) * | 2004-03-24 | 2005-09-29 | The Council Of The Queensland Institute Of Medical Research | Cancer and testis vsm1 and vsm2 nucleic acids, proteins and uses thereof |
KR101204286B1 (en) * | 2004-03-30 | 2012-11-26 | 엔에스진 에이/에스 | Therapeutic use of a growth factor, NsG33 |
JP5813908B2 (en) | 2004-04-09 | 2015-11-17 | ジェノミック ヘルス, インコーポレイテッド | Gene expression markers to predict response to chemotherapeutic agents |
DE102004024617A1 (en) | 2004-05-18 | 2005-12-29 | Ganymed Pharmaceuticals Ag | Differentially expressed in tumors gene products and their use |
WO2005118832A2 (en) * | 2004-06-01 | 2005-12-15 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase-like protein (sgkl) |
WO2006002437A2 (en) | 2004-06-24 | 2006-01-05 | Biogen Idec Ma Inc. | Treatment of conditions involving demyelination |
US7587279B2 (en) | 2004-07-06 | 2009-09-08 | Genomic Health | Method for quantitative PCR data analysis system (QDAS) |
EP1780215B1 (en) * | 2004-08-05 | 2009-06-17 | Toagosei Co., Ltd. | Crohn's disease antibody epitope peptide and reagent for testing crohn's disease |
US7930104B2 (en) | 2004-11-05 | 2011-04-19 | Genomic Health, Inc. | Predicting response to chemotherapy using gene expression markers |
DK1815014T3 (en) | 2004-11-05 | 2012-06-18 | Genomic Health Inc | Molecular indicators of breast cancer prognosis and prediction of treatment response |
EP2314618A3 (en) | 2004-11-12 | 2011-10-19 | Xencor Inc. | Fc variants with altered binding to FcRn |
US8367805B2 (en) | 2004-11-12 | 2013-02-05 | Xencor, Inc. | Fc variants with altered binding to FcRn |
US7851445B2 (en) | 2005-03-04 | 2010-12-14 | Northwestern University | Angiogenic heparin-binding epitopes, peptide amphiphiles, self-assembled compositions and related methods of use |
EP1880005B1 (en) * | 2005-05-13 | 2012-11-07 | Centre National de la Recherche Scientifique | Mcm9, a member of the mcm2-8 family and its use in pharmaceutical compositions |
EP2238986A3 (en) | 2005-07-08 | 2010-11-03 | Biogen Idec MA Inc. | Sp35 antibodies and uses thereof |
EP1907589A4 (en) * | 2005-07-26 | 2010-11-24 | Siemens Healthcare Diagnostics | Single nucleotide polymorphisms associated with susceptibility to cardiovascular disease |
WO2007037601A1 (en) * | 2005-09-28 | 2007-04-05 | Knu-Industry Cooperation Foundation | Polypeptide inhibiting transmigration of leukocytes or growth and/or metastasis of cancer cells, and fusion protein thereof |
EP1790664A1 (en) | 2005-11-24 | 2007-05-30 | Ganymed Pharmaceuticals AG | Monoclonal antibodies against claudin-18 for treatment of cancer |
EP1969003B8 (en) | 2005-12-14 | 2010-11-10 | Hermo Pharma Ltd. | Uses of a NEUROTROPHIC FACTOR PROTEIN |
AU2007271232A1 (en) * | 2006-07-03 | 2008-01-10 | Exonhit Therapeutics Sa | Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics |
US20080108070A1 (en) * | 2006-09-08 | 2008-05-08 | Corixa Corporation | Methods, compositions, and kits for the detection and monitoring of colon cancer |
US8076295B2 (en) | 2007-04-17 | 2011-12-13 | Nanotope, Inc. | Peptide amphiphiles having improved solubility and methods of using same |
US8999634B2 (en) * | 2007-04-27 | 2015-04-07 | Quest Diagnostics Investments Incorporated | Nucleic acid detection combining amplification with fragmentation |
GB0805159D0 (en) | 2008-03-19 | 2008-04-23 | Sancho Madrid David | Immune modulation via C-type lectin |
ES2555282T3 (en) * | 2007-07-27 | 2015-12-30 | Immatics Biotechnologies Gmbh | New immunogenic epitopes for immunotherapy |
US7863021B2 (en) | 2007-09-05 | 2011-01-04 | Celera Corporation | Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof |
WO2009034661A1 (en) * | 2007-09-12 | 2009-03-19 | Toppan Printing Co., Ltd. | Method for diagnosis and induction of resistance to virus |
DK2216340T3 (en) | 2007-10-17 | 2013-03-11 | Univ Cordoba | Isoforms of Alternative Treatment Human Type 5 Somatostatin Receptors and Oligonucleotide Pairs for Detection thereof by PCR |
ES2742268T3 (en) | 2007-12-26 | 2020-02-13 | Xencor Inc | Fc variants with altered FcRn binding |
GB0803352D0 (en) | 2008-02-22 | 2008-04-02 | Ntnu Technology Transfer As | Oligopeptidic compounds and uses thereof |
US9683031B2 (en) | 2008-03-21 | 2017-06-20 | Universiteit Hasselt | Biomarkers for rheumatoid arthritis |
US8058406B2 (en) | 2008-07-09 | 2011-11-15 | Biogen Idec Ma Inc. | Composition comprising antibodies to LINGO or fragments thereof |
AU2009273600B2 (en) | 2008-07-24 | 2013-04-18 | Hoba Therapeutics Aps | Therapeutic use of a growth factor, METRNL |
ES2536465T3 (en) | 2008-10-01 | 2015-05-25 | Immatics Biotechnologies Gmbh | Composition of tumor-associated and cancer-related peptides for the treatment of glioblastoma (GBM) and other cancers |
EP2358908B1 (en) | 2008-11-14 | 2014-01-08 | Gen-Probe Incorporated | Compositions and methods for detection of campylobacter nucleic acid |
WO2010062960A2 (en) | 2008-11-26 | 2010-06-03 | Cedars-Sinai Medical Center | METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE |
US20110286924A1 (en) * | 2008-12-09 | 2011-11-24 | Alethia Biotherapeutics Inc | Novel human endogenous retroviral erv3 variant and uses thereof in the diagnosing ovarian cancer |
WO2010120830A1 (en) | 2009-04-13 | 2010-10-21 | Northwestern University | Novel peptide-based scaffolds for cartilage regeneration and methods for their use |
US9493578B2 (en) | 2009-09-02 | 2016-11-15 | Xencor, Inc. | Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens |
AU2011210840B2 (en) * | 2010-01-27 | 2014-12-11 | Massachusetts Institute Of Technology | Engineered polypeptide agents for targeted broad spectrum influenza neutralization |
KR102504750B1 (en) | 2010-09-29 | 2023-03-02 | 어젠시스 인코포레이티드 | Antibody drug conjugates (adc) that bind to 191p4d12 proteins |
CN108079279B (en) | 2010-10-01 | 2022-04-12 | 霍巴治疗公司 | Use of nickel-line protein for treating allodynia, hyperalgesia, spontaneous pain and phantom pain |
ES2677699T3 (en) | 2010-12-14 | 2018-08-06 | Hananja Ehf | Biological activity of placental protein 13 |
US9474786B2 (en) | 2011-09-05 | 2016-10-25 | Nsgene A/S | Treatment of allodynia |
WO2013068445A1 (en) * | 2011-11-09 | 2013-05-16 | Sanofi | Diacylglycerol lipase and uses thereof |
DK3489254T3 (en) | 2012-04-30 | 2022-11-07 | Biocon Ltd | TARGETED/IMMUNOMODULATORY FUSION PROTEINS AND METHODS OF MANUFACTURE THEREOF |
WO2013167153A1 (en) | 2012-05-09 | 2013-11-14 | Ganymed Pharmaceuticals Ag | Antibodies useful in cancer diagnosis |
JP2015518829A (en) | 2012-05-14 | 2015-07-06 | バイオジェン・エムエイ・インコーポレイテッドBiogen MA Inc. | LINGO-2 antagonist for treatment of conditions involving motor neurons |
WO2013174404A1 (en) | 2012-05-23 | 2013-11-28 | Ganymed Pharmaceuticals Ag | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
MX369276B (en) | 2012-11-13 | 2019-11-04 | Biontech Ag | Agents for treatment of claudin expressing cancer diseases. |
WO2014127785A1 (en) | 2013-02-20 | 2014-08-28 | Ganymed Pharmaceuticals Ag | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
US9023353B2 (en) * | 2013-03-13 | 2015-05-05 | The Board Of Trustees Of The University Of Arkansas | Anti-(+)—methamphetamine monoclonal antibodies |
WO2014146672A1 (en) | 2013-03-18 | 2014-09-25 | Ganymed Pharmaceuticals Ag | Therapy involving antibodies against claudin 18.2 for treatment of cancer |
JP6671276B2 (en) | 2013-03-27 | 2020-03-25 | セダーズ−シナイ メディカル センター | Alleviation and recovery of fibrosis and inflammation by suppression of TL1A function and related signaling pathways |
LT3019619T (en) | 2013-07-11 | 2021-12-10 | Modernatx, Inc. | Compositions comprising synthetic polynucleotides encoding crispr related proteins and synthetic sgrnas and methods of use |
EP3022295A4 (en) | 2013-07-19 | 2017-03-01 | Cedars-Sinai Medical Center | Signature of tl1a (tnfsf15) signaling pathway |
RU2020106752A (en) | 2013-09-25 | 2020-03-11 | Сайтомкс Терапьютикс, Инк. | SUBSTRATES OF MATRIX METALLOPROTEINASES AND OTHER DISSOLIDABLE FRAGMENTS AND METHODS FOR USING THEM |
CA2925658C (en) | 2013-10-01 | 2022-12-06 | Mie University | Long chain antigen containing interepitope sequence that promotes antigen presentation to t cells |
EP4176896A1 (en) | 2014-01-31 | 2023-05-10 | Cytomx Therapeutics Inc. | Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof |
EP3242893A1 (en) | 2015-01-08 | 2017-11-15 | Biogen MA Inc. | Lingo-1 antagonists and uses for treatment of demyelinating disorders |
MA41374A (en) | 2015-01-20 | 2017-11-28 | Cytomx Therapeutics Inc | MATRIX METALLOPROTEASE CLIVABLE AND SERINE PROTEASE CLIVABLE SUBSTRATES AND METHODS OF USE THEREOF |
EP3307070A4 (en) * | 2015-06-12 | 2019-01-02 | Emory University | Growth and survival compositions for cells capable of producing antibodies and methods related thereto |
US10351869B2 (en) * | 2015-09-04 | 2019-07-16 | Synthetic Genomics, Inc. | Microorganisms engineered for increased productivity |
KR102464372B1 (en) | 2016-03-17 | 2022-11-04 | 세다르스-신나이 메디칼 센터 | Methods of diagnosing inflammatory bowel disease through rnaset2 |
WO2017172941A2 (en) * | 2016-03-29 | 2017-10-05 | Berz David | Modulation of structural maintenance of chromosome-1 expression |
US9611297B1 (en) | 2016-08-26 | 2017-04-04 | Thrasos Therapeutics Inc. | Compositions and methods for the treatment of cast nephropathy and related conditions |
US11125757B2 (en) | 2017-05-26 | 2021-09-21 | Emory University | Methods of culturing and characterizing antibody secreting cells |
EP3508499A1 (en) | 2018-01-08 | 2019-07-10 | iOmx Therapeutics AG | Antibodies targeting, and other modulators of, an immunoglobulin gene associated with resistance against anti-tumour immune responses, and uses thereof |
CA3146023A1 (en) | 2019-07-05 | 2021-01-14 | Iomx Therapeutics Ag | Antibodies binding igc2 of igsf11 (vsig3) and uses thereof |
WO2021083958A1 (en) * | 2019-10-29 | 2021-05-06 | Specialites Pet Food | Novel peptides inducing satiety |
EP4149952A1 (en) * | 2020-05-12 | 2023-03-22 | Institut Curie | Neoantigenic epitopes associated with sf3b1 mutations |
WO2022008027A1 (en) | 2020-07-06 | 2022-01-13 | Iomx Therapeutics Ag | Antibodies binding igv of igsf11 (vsig3) and uses thereof |
AU2022209669A1 (en) * | 2021-01-21 | 2023-08-10 | Erasmus University Medical Center Rotterdam | T cells for use in therapy |
AU2022222756A1 (en) * | 2021-02-18 | 2023-09-14 | Beren Therapeutics P.B.C. | Methods for the treatment of familial heterozygous and homozygous hypercholesterolemia with cyclodextrins |
WO2023225602A1 (en) * | 2022-05-20 | 2023-11-23 | Medikine, Inc. | Interleukin-18 receptor binding polypeptides and uses thereof |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4446240A (en) * | 1981-01-30 | 1984-05-01 | Nerenberg Samuel T | Pancreas specific protein systems |
US5457038A (en) * | 1988-11-10 | 1995-10-10 | Genetics Institute, Inc. | Natural killer stimulatory factor |
US6080540A (en) * | 1990-04-20 | 2000-06-27 | Cold Spring Harbor Laboratory | Cloning of mammalian genes in microbial organisms and methods for pharmacological screening |
WO1992009617A1 (en) * | 1990-11-26 | 1992-06-11 | The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce | Cell stress transcriptional factors |
US5721352A (en) * | 1991-02-19 | 1998-02-24 | University Of Florida Research Foundation | Entomopoxvirus expression system |
US5840870A (en) * | 1995-12-29 | 1998-11-24 | Incyte Pharmaceuticals, Inc. | Polynucleotides PANC1A and PANC1B associated with pancreatic cancer |
WO1999014234A2 (en) * | 1997-09-17 | 1999-03-25 | Genentech, Inc. | Promotion or inhibition of angiogenesis and cardiovascularization |
WO1997007827A1 (en) * | 1995-08-22 | 1997-03-06 | Thomas Jefferson University | Gab1, A Grb2 BINDING PROTEIN, AND COMPOSITIONS FOR MAKING AND METHODS OF USING THE SAME |
JP3462313B2 (en) * | 1995-08-24 | 2003-11-05 | キッコーマン株式会社 | Mutant uricase, mutant uricase gene, novel recombinant DNA, and method for producing mutant uricase |
US5998165A (en) * | 1995-12-29 | 1999-12-07 | Incyte Pharmaceuticals, Inc. | Polynucleotides encoding a protein associated with pancreatic cancer |
AU721105B2 (en) * | 1996-04-29 | 2000-06-22 | Johns Hopkins University School Of Medicine, The | Mammalian regulator of nonsense-mediated RNA decay |
US6500934B1 (en) * | 1996-07-24 | 2002-12-31 | Michael Rush Lerner | Bivalent agonists for G-protein coupled receptors |
US5976834A (en) * | 1997-01-09 | 1999-11-02 | Smithkline Beecham Corporation | cDNA clone HNFJD15 that encodes a novel human 7-transmembrane receptor |
US5925521A (en) * | 1997-03-31 | 1999-07-20 | Incyte Pharmaceuticals, Inc. | Human serine carboxypeptidase |
CA2232743A1 (en) * | 1997-04-02 | 1998-10-02 | Smithkline Beecham Corporation | A tnf homologue, tl5 |
EP0973898A2 (en) * | 1997-04-10 | 2000-01-26 | Genetics Institute, Inc. | SECRETED EXPRESSED SEQUENCE TAGS (sESTs) |
IT1291110B1 (en) * | 1997-04-15 | 1998-12-29 | Istituto Europ Di Oncologia S | INTRACELLULAR INTERACTORS AND BINDING SPECIFICITY OF THE DOMAIN EH |
US5948641A (en) * | 1997-05-29 | 1999-09-07 | Incyte Pharmaceuticals, Inc. | Polynucleotides encoding a metal response element binding protein |
WO1998055620A1 (en) * | 1997-06-06 | 1998-12-10 | Regeneron Pharmaceuticals, Inc. | Ntn-2 member of tnf ligand family |
US5932442A (en) * | 1997-09-23 | 1999-08-03 | Incyte Pharmaceuticals, Inc. | Human regulatory molecules |
US5972660A (en) * | 1997-10-22 | 1999-10-26 | Incyte Pharmaceuticals, Inc. | Human hydroxypyruvate reductase |
DE19818598A1 (en) * | 1998-04-19 | 1999-10-21 | Metagen Gesellschaft Fuer Genomforschung Mbh | New nucleic acid sequences expressed in normal pancreatic tissues, and derived polypeptides, for treatment of pancreatic cancer and identification of therapeutic agents |
WO1999055865A1 (en) * | 1998-04-29 | 1999-11-04 | Genesis Research And Development Corporation Limited | Polynucleotides isolated from skin cells and methods for their use |
US6262249B1 (en) * | 1998-06-23 | 2001-07-17 | Chiron Corporation | Pancreatic cancer genes |
CA2296792A1 (en) * | 1999-02-26 | 2000-08-26 | Genset S.A. | Expressed sequence tags and encoded human proteins |
-
2001
- 2001-01-17 CA CA002392438A patent/CA2392438A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001357 patent/WO2001055208A1/en not_active Application Discontinuation
- 2001-01-17 WO PCT/US2001/001353 patent/WO2001055206A1/en not_active Application Discontinuation
- 2001-01-17 WO PCT/US2001/001355 patent/WO2001055207A1/en not_active Application Discontinuation
- 2001-01-17 WO PCT/US2001/001327 patent/WO2001055203A1/en active Search and Examination
- 2001-01-17 CA CA002395178A patent/CA2395178A1/en not_active Withdrawn
- 2001-01-17 CA CA002398411A patent/CA2398411A1/en not_active Withdrawn
- 2001-01-17 AU AU2001241410A patent/AU2001241410A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001341 patent/WO2001055322A2/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001335 patent/WO2001055319A2/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001313 patent/WO2001055200A1/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001330 patent/WO2001055447A1/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001349 patent/WO2001054474A2/en active Search and Examination
- 2001-01-17 AU AU2001241406A patent/AU2001241406A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001239 patent/WO2001055301A2/en active Search and Examination
- 2001-01-17 AU AU2001241418A patent/AU2001241418A1/en not_active Abandoned
- 2001-01-17 AU AU2001250770A patent/AU2001250770A1/en not_active Abandoned
- 2001-01-17 AU AU2001241414A patent/AU2001241414A1/en not_active Abandoned
- 2001-01-17 CA CA002395872A patent/CA2395872A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001344 patent/WO2001055324A2/en active Search and Examination
- 2001-01-17 CA CA002393912A patent/CA2393912A1/en not_active Withdrawn
- 2001-01-17 CA CA002392398A patent/CA2392398A1/en not_active Abandoned
- 2001-01-17 CA CA002395699A patent/CA2395699A1/en active Pending
- 2001-01-17 CA CA002398877A patent/CA2398877A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001348 patent/WO2001055368A1/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001306 patent/WO2001055307A2/en active Search and Examination
- 2001-01-17 CA CA002392751A patent/CA2392751A1/en not_active Abandoned
- 2001-01-17 CA CA002395693A patent/CA2395693A1/en active Pending
- 2001-01-17 CA CA002395666A patent/CA2395666A1/en not_active Withdrawn
- 2001-01-17 CA CA002393002A patent/CA2393002A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001310 patent/WO2001055387A1/en active Search and Examination
- 2001-01-17 AU AU2001241408A patent/AU2001241408A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001315 patent/WO2001055311A2/en active Search and Examination
- 2001-01-17 AU AU2001241407A patent/AU2001241407A1/en not_active Abandoned
- 2001-01-17 CA CA002394039A patent/CA2394039A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001338 patent/WO2001055367A1/en active Search and Examination
- 2001-01-17 CA CA002395654A patent/CA2395654A1/en not_active Withdrawn
- 2001-01-17 CA CA002395398A patent/CA2395398A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001339 patent/WO2001055320A2/en not_active Application Discontinuation
- 2001-01-17 WO PCT/US2001/001314 patent/WO2001055310A2/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001351 patent/WO2001055355A1/en active Search and Examination
- 2001-01-17 CA CA002395729A patent/CA2395729A1/en active Pending
- 2001-01-17 WO PCT/US2001/001342 patent/WO2001059064A2/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001324 patent/WO2001055314A2/en active Search and Examination
- 2001-01-17 CA CA002395724A patent/CA2395724A1/en active Pending
- 2001-01-17 WO PCT/US2001/001345 patent/WO2001055325A2/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001312 patent/WO2001054733A1/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001322 patent/WO2001055343A1/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001343 patent/WO2001055323A2/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001321 patent/WO2001055312A2/en active Search and Examination
- 2001-01-17 CA CA002395816A patent/CA2395816A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001301 patent/WO2001055303A2/en not_active Application Discontinuation
- 2001-01-17 CA CA002395787A patent/CA2395787A1/en not_active Withdrawn
- 2001-01-17 CA CA002395403A patent/CA2395403A1/en not_active Withdrawn
- 2001-01-17 AU AU2001241412A patent/AU2001241412A1/en not_active Abandoned
- 2001-01-17 CA CA002392428A patent/CA2392428A1/en not_active Abandoned
- 2001-01-17 CA CA002392422A patent/CA2392422A1/en not_active Abandoned
- 2001-01-17 CA CA002397839A patent/CA2397839A1/en not_active Withdrawn
- 2001-01-17 CA CA002395827A patent/CA2395827A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001332 patent/WO2001055318A2/en active Search and Examination
- 2001-01-17 CA CA002395849A patent/CA2395849A1/en active Pending
- 2001-01-17 AU AU2001241413A patent/AU2001241413A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001316 patent/WO2001054473A2/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001325 patent/WO2001055202A1/en active Search and Examination
- 2001-01-17 AU AU2001241417A patent/AU2001241417A1/en not_active Abandoned
- 2001-01-17 CA CA002392450A patent/CA2392450A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001240 patent/WO2001055302A2/en not_active Application Discontinuation
- 2001-01-17 CA CA002392757A patent/CA2392757A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001308 patent/WO2001055364A2/en active Search and Examination
- 2001-01-17 AU AU2001241416A patent/AU2001241416A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001326 patent/WO2001055315A2/en active Search and Examination
- 2001-01-17 AU AU2001241409A patent/AU2001241409A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001333 patent/WO2001055448A1/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001358 patent/WO2001055163A1/en not_active Application Discontinuation
- 2001-01-17 CA CA002395734A patent/CA2395734A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001337 patent/WO2001055205A1/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001356 patent/WO2001055173A2/en not_active Application Discontinuation
- 2001-01-17 CA CA002395295A patent/CA2395295A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001309 patent/WO2001055308A2/en active Search and Examination
- 2001-01-17 AU AU2001241405A patent/AU2001241405A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001354 patent/WO2001057182A2/en not_active Application Discontinuation
- 2001-01-17 CA CA002395858A patent/CA2395858A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001311 patent/WO2001055309A2/en active Search and Examination
- 2001-01-17 CA CA002393652A patent/CA2393652A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001302 patent/WO2001055304A2/en active Search and Examination
- 2001-01-17 CA CA002395671A patent/CA2395671A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001340 patent/WO2001055321A2/en active Search and Examination
- 2001-01-17 CA CA002397407A patent/CA2397407A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001328 patent/WO2001055316A2/en active Search and Examination
- 2001-01-17 CA CA002395738A patent/CA2395738A1/en not_active Withdrawn
- 2001-01-17 CA CA002393618A patent/CA2393618A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001350 patent/WO2001055350A1/en active Search and Examination
- 2001-01-17 AU AU2001241415A patent/AU2001241415A1/en not_active Abandoned
- 2001-01-17 WO PCT/US2001/001336 patent/WO2001055204A1/en active Search and Examination
- 2001-01-17 WO PCT/US2001/001359 patent/WO2001055328A2/en active Application Filing
- 2001-01-17 WO PCT/US2001/001352 patent/WO2001055327A2/en not_active Application Discontinuation
- 2001-01-17 CA CA002395885A patent/CA2395885A1/en not_active Withdrawn
- 2001-01-17 CA CA002394841A patent/CA2394841A1/en not_active Withdrawn
- 2001-01-17 WO PCT/US2001/001317 patent/WO2001055201A1/en active Search and Examination
- 2001-02-05 AU AU4313701A patent/AU4313701A/en active Pending
- 2001-02-08 AU AU4141101A patent/AU4141101A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8932821B2 (en) | 2003-03-19 | 2015-01-13 | Biogen Idec Ma Inc. | NOGO receptor binding protein |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001055320A8 (en) | Nucleic acids, proteins, and antibodies | |
WO2001059063A3 (en) | Nucleic acids, proteins, and antibodies | |
WO2002000677A8 (en) | Nucleic acids, proteins, and antibodies | |
WO2001055317A8 (en) | Nucleic acids, proteins, and antibodies | |
WO2001055300A3 (en) | Nucleic acids, proteins, and antibodies | |
WO2001055313A8 (en) | Nucleic acids, proteins, and antibodies | |
WO2001055329A8 (en) | Nucleic acids, proteins, and antibodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
AK | Designated states |
Kind code of ref document: C1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: PAT. BUL. 31/2001 UNDER "PUBLISHED," REPLACE "ENTIRELY IN ELECTRONIC FORM (EXCEPT FOR THE FRONT PAGE) AND AVAILABLE UPON REQUEST FROM THE INTERNATIONAL BUREAU." BY "WITH SEQUENCE LISTING PART OF DESCRIPTION PUBLISHED SEPARATELY IN ELECTRONIC FORM AND AVAILABLE UPON REQUEST FROM THE INTERNATIONAL BUREAU." |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001916066 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001916066 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |